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The improvement in pain free walking distance with exercise
by patients with claudication may rival that achieved with interven-
tion.1 The mechanisms underlying this improvement are believed
to be the enlargement of existing collaterals and development of
new vessels in response to the repeated demand for additional
ﬂow. Certainly, there are impressive differences in collateral devel-
opment between patients with similar obstructions to inline arterial
ﬂow, but how much of this represents existing vessel dilation or
new vessel development and to what degree a rich collateral bed
is intrinsic to the unique anatomy and biology of the individual
affected remain important unanswered questions.
In this issue of the Journal of Vascular Surgery, Dr Versluis
and colleagues have attempted to add science to the mystery.2
They studied 10 patients using contrast-enhanced magnetic reso-
nance angiography to assess collateral number before and after
a 6-month supervised exercise program. Pain free walking distance
improved by 71%, but the number of collaterals identiﬁed, peak
arterial ﬂow, and ankle brachial index values did not.
Versluis’ study is not deﬁnitive. The number of patients is
small, ﬂow measurements were made in only six of the 10 subjects,
and collateral development could have been below the level of
detection with contrast-enhanced magnetic resonance angiog-
raphy. Nonetheless, their study adds to others suggesting that
the response to exercise may be much more complex than simplyincreasing blood ﬂow. For example, arm-ergometry is reported to
increase walking distance in claudicants.3 The response to exercise
in peripheral artery disease begs for carefully performed prospective
studies with more sensitive methods for collateral assessment,
documentation of systemic and skeletal muscle responses, and
biomarker assays. It is hoped that Versluis and colleagues will
continue to reﬁne their work and stimulate others to join in this
important effort.REFERENCES
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